SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-056838
Filing Date
2024-05-09
Accepted
2024-05-09 16:00:50
Documents
72
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cue-20240331.htm   iXBRL 10-Q 1153830
2 EX-31.1 cue-ex31_1.htm EX-31.1 12541
3 EX-31.2 cue-ex31_2.htm EX-31.2 12664
4 EX-32.1 cue-ex32_1.htm EX-32.1 10307
5 GRAPHIC img77944571_0.jpg GRAPHIC 28234
6 GRAPHIC img77944571_1.jpg GRAPHIC 142670
7 GRAPHIC img77944571_2.jpg GRAPHIC 70969
8 GRAPHIC img77944571_3.jpg GRAPHIC 130090
9 GRAPHIC img77944571_4.jpg GRAPHIC 63904
10 GRAPHIC img77944571_5.jpg GRAPHIC 19274
11 GRAPHIC img77944571_6.jpg GRAPHIC 13798
12 GRAPHIC img77944571_7.jpg GRAPHIC 18736
  Complete submission text file 0000950170-24-056838.txt   7586712

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cue-20240331.xsd EX-101.SCH 1412758
75 EXTRACTED XBRL INSTANCE DOCUMENT cue-20240331_htm.xml XML 826773
Mailing Address 40 GUEST STREET BOSTON MA 02135
Business Address 40 GUEST STREET BOSTON MA 02135 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

IRS No.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38327 | Film No.: 24930271
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)